Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Treasury Shares: 2013-2025

Historic Treasury Shares for Ptc Therapeutics (PTCT) over the last 13 years, with Sep 2025 value amounting to $3.8 million.

  • Ptc Therapeutics' Treasury Shares rose 5.35% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 million, marking a year-over-year increase of 5.35%. This contributed to the annual value of $3.5 million for FY2024, which is 23.07% up from last year.
  • As of Q3 2025, Ptc Therapeutics' Treasury Shares stood at $3.8 million, which was down 0.78% from $3.8 million recorded in Q2 2025.
  • In the past 5 years, Ptc Therapeutics' Treasury Shares registered a high of $3.9 million during Q1 2025, and its lowest value of $1.5 million during Q1 2021.
  • Over the past 3 years, Ptc Therapeutics' median Treasury Shares value was $3.6 million (recorded in 2023), while the average stood at $3.6 million.
  • Its Treasury Shares has fluctuated over the past 5 years, first skyrocketed by 68.27% in 2022, then decreased by 0.39% in 2024.
  • Ptc Therapeutics' Treasury Shares (Quarterly) stood at $1.5 million in 2021, then surged by 65.57% to $2.5 million in 2022, then increased by 13.91% to $2.9 million in 2023, then grew by 23.07% to $3.5 million in 2024, then rose by 5.35% to $3.8 million in 2025.
  • Its Treasury Shares was $3.8 million in Q3 2025, compared to $3.8 million in Q2 2025 and $3.9 million in Q1 2025.